Skip to content
1 min left
0% read
Sweetwater Digital Asset Consulting logo

Sweetwater Digital Asset Consulting

Investment Firm
Founded 2018

Sweetwater Digital Asset Consulting is an Investment management company established by Dr

Share:

Sweetwater Digital Asset Consulting

Sweetwater Digital Asset Consulting is an investment management company established by Dr. Daniel Kim in 2018 and headquartered in Massachusetts. The consulting link between "old money" industries like sophisticated trust and estate planning, structural asset protection, and legacy wealth and portfolio management and "new money" industries like non-commercial, open-source, grass-roots cryptocurrency projects.

Sweetwater Digital Asset Consulting provides help to “new money” clients and “old money” clients to substantially benefit from the ideas, insights, and strategies that the “other” side can offer.

Frequently Asked Questions About Sweetwater Digital Asset Consulting

Sweetwater Digital Asset Consulting is a finance company. Sweetwater Digital Asset Consulting is an Investment management company established by Dr

Sweetwater Digital Asset Consulting is an Investment management company established by Dr. Daniel Kim in 2018.

Sweetwater Digital Asset Consulting has been operating since 2018. You can verify their legitimacy through their official website and social media presence.

Sweetwater Digital Asset Consulting operates in the finance sector of the cryptocurrency industry. Compare Sweetwater Digital Asset Consulting with other finance companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using Sweetwater Digital Asset Consulting, research their track record (operating since 2018), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. Sweetwater Digital Asset Consulting has been operating since 2018. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

Sweetwater Digital Asset Consulting was founded in 2018.

Sweetwater Digital Asset Consulting was founded in 2018.

Sweetwater Digital Asset Consulting Details

Sweetwater Digital Asset Consulting Tags

More About Sweetwater Digital Asset Consulting

Latest from Academy

Blast Ecosystem Grew 400% in Six Months and Nobody Talked About It

Blast Ecosystem Grew 400% in Six Months and Nobody Talked About It

The Blast ecosystem has been crypto's most misunderstood narrative of 2026. While the market fixated on a 98.3% drawdown from all-time highs, less-publicized on-chain data tells a counterintuitive story. Three major protocol upgrades shipped since January 2025, 10% TVL growth appeared week-on-week in April, and 279,520 holders remain HODLing their positions on a chain the world has given up on.

7m
 Why Tokenlon's Revenue Doesn't Match Its Token Price

Why Tokenlon's Revenue Doesn't Match Its Token Price

DEX aggregation is "solved" in DeFi, right? 1inch, Jupiter, Paraswap have you covered. Except the data paints a different picture. Tokenlon quietly processes over $120 million in weekly trading volume and a 99.71% order success rate, yet remains shockingly absent from discussion in industry forums and panels. Either the market is correct and Tokenlon's fundamentals are not what we perceive, or a highly-traveled protocol has been willfully ignored.

Mia Halland logoMia HallandApr 26, 2026
8m
Sixty-Five Million in BioDAOs, BIO at One Cent

Sixty-Five Million in BioDAOs, BIO at One Cent

Bio Protocol's CEO recently revealed that PeptAI designed a new ADHD peptide candidate in 24 hours for roughly $1,500 in initial lab validation. While crypto traders focus on memecoins, Bio Protocol has quietly built a scientific funding platform backed by Pfizer Ventures, Binance Labs, and Arthur Hayes' Maelstrom Fund. The bio price trades at $0.031, down 96.5% from its all-time high of $0.889, despite $65M in combined BioDAO research funding and active clinical trials.

8m